Endoscopic Chemocauterization with Trichloroacetic Acid for Congenital or Recurrent Tracheoesophageal Fistula in Children with Esophageal Atresia: Experience from a Tertiary Center

jpedsurg.org

Recurrent tracheoesophageal fistula (rTEF) is a well-known complication after surgery of EA, occurring in roughly 3–10% of the patients. Recent studies have highlighted safety and efficacy of endoscopic management of recurrent TEF. The aim of this study was to evaluate the efficacy of chemocauterization with trichloroacetic acid (TCA) in rTEF and congenital tracheoesophageal fistula (cTEF).

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Oct 2023 · 1 min read

In brief

This study evaluates endoscopic chemocauterization using trichloroacetic acid as a minimally invasive treatment option for recurrent and congenital tracheoesophageal fistulas in children with esophageal atresia. The approach offers a less invasive alternative to surgical re-intervention for managing this 3-10% postoperative complication.

Recurrent tracheoesophageal fistula occurs in 3-10% of patients after esophageal atresia repair
Endoscopic chemocauterization with trichloroacetic acid offers a minimally invasive treatment option for recurrent TEF
TCA chemocauterization can be effective for both recurrent and congenital tracheoesophageal fistulas
Endoscopic management avoids repeat thoracotomy and associated surgical morbidity in pediatric patients

Written by the GCMD Library team from the article.

Read it at the source ↗